chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: I feel nauseous today; Itchy; Warm to touch; The bump is about 4 inches long and 3 inches wide; Red Raised area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE SWELLING (The bump is about 4 inches long and 3 inches wide), VACCINATION SITE ERYTHEMA (Red Raised area at the injection site) and NAUSEA (I feel nauseous today) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE SWELLING (The bump is about 4 inches long and 3 inches wide) and VACCINATION SITE ERYTHEMA (Red Raised area at the injection site). On 25-Jan-2021, the patient experienced NAUSEA (I feel nauseous today). At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE SWELLING (The bump is about 4 inches long and 3 inches wide), VACCINATION SITE ERYTHEMA (Red Raised area at the injection site) and NAUSEA (I feel nauseous today) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy rash that extended to both lower legs and tops of feet & both lower arms & backs of hand & both ears; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (Itchy rash that extended to both lower legs and tops of feet & both lower arms & backs of hand & both ears) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced RASH PRURITIC (Itchy rash that extended to both lower legs and tops of feet & both lower arms & backs of hand & both ears). At the time of the report, RASH PRURITIC (Itchy rash that extended to both lower legs and tops of feet & both lower arms & backs of hand & both ears) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided Treatment Benadryl, hydrocortisone cream, Medrol Dose Pack
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Myalgia, Paraesthesia
Clinical narrative: Tingly; Weakness; Joint Pain; Muscle Pain; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingly), ASTHENIA (Weakness), ARTHRALGIA (Joint Pain) and MYALGIA (Muscle Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L209) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingly), ASTHENIA (Weakness), ARTHRALGIA (Joint Pain) and MYALGIA (Muscle Pain). At the time of the report, PARAESTHESIA (Tingly), ASTHENIA (Weakness), ARTHRALGIA (Joint Pain) and MYALGIA (Muscle Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided Treatment Tylenol, Motrin
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: redness of the injection site still getting bigger; Injection site was warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Injection site was warm to touch) and INJECTION SITE ERYTHEMA (redness of the injection site still getting bigger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced INJECTION SITE WARMTH (Injection site was warm to touch). On 17-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (redness of the injection site still getting bigger). At the time of the report, INJECTION SITE WARMTH (Injection site was warm to touch) and INJECTION SITE ERYTHEMA (redness of the injection site still getting bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment The patient has took Tylenol, Benadryl, and Keflex for a week. Nothing seems to be helping.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Feeling hot, Rash
Clinical narrative: Felt hot; Burning feeling; Rash on arms, on both legs; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt hot), BURNING SENSATION (Burning feeling) and RASH (Rash on arms, on both legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING HOT (Felt hot), BURNING SENSATION (Burning feeling) and RASH (Rash on arms, on both legs). At the time of the report, FEELING HOT (Felt hot) and BURNING SENSATION (Burning feeling) outcome was unknown and RASH (Rash on arms, on both legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided Treatment Benadryl
Sex: F
Vaccine: COVID19
Symptoms: Injection site joint warmth, Injection site mass, Peripheral swelling, Pruritus, Urticaria
Clinical narrative: Knots at injection site; Fever in spot of injection; Welts; Itching; Swollen arms; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Knots at injection site), INJECTION SITE JOINT WARMTH (Fever in spot of injection), URTICARIA (Welts), PRURITUS (Itching) and PERIPHERAL SWELLING (Swollen arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJECTION SITE MASS (Knots at injection site), INJECTION SITE JOINT WARMTH (Fever in spot of injection), URTICARIA (Welts), PRURITUS (Itching) and PERIPHERAL SWELLING (Swollen arms). At the time of the report, INJECTION SITE MASS (Knots at injection site), INJECTION SITE JOINT WARMTH (Fever in spot of injection), URTICARIA (Welts), PRURITUS (Itching) and PERIPHERAL SWELLING (Swollen arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain
Clinical narrative: Pain; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) and ERYTHEMA (Redness) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jan-2021, the patient experienced PAIN (Pain) and ERYTHEMA (Redness). At the time of the report, PAIN (Pain) and ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little arm pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little arm pain). At the time of the report, PAIN IN EXTREMITY (little arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Oxygen saturation, Pyrexia
Clinical narrative: temperature of 101.94 ºF; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (temperature of 101.94 ºF) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (temperature of 101.94 ºF). At the time of the report, PYREXIA (temperature of 101.94 ºF) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 101.94 ºf (Inconclusive) 101.94 ºF. In 2021, Oxygen saturation: 92 (Inconclusive) 92.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided    Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided    This case was linked to MOD-2021-012462 (Linked Report).; Sender's Comments:  MOD-2021-012462:same reporter, different patient
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site lymphadenopathy, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: area was slightly warm; area was tender, achiness in the right deltoid; area was pink; area was swollen; small swollen lymph nodes; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (area was slightly warm), VACCINATION SITE PAIN (area was tender, achiness in the right deltoid), VACCINATION SITE ERYTHEMA (area was pink), VACCINATION SITE SWELLING (area was swollen) and VACCINATION SITE LYMPHADENOPATHY (small swollen lymph nodes) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (area was slightly warm), VACCINATION SITE PAIN (area was tender, achiness in the right deltoid), VACCINATION SITE ERYTHEMA (area was pink), VACCINATION SITE SWELLING (area was swollen) and VACCINATION SITE LYMPHADENOPATHY (small swollen lymph nodes). At the time of the report, VACCINATION SITE WARMTH (area was slightly warm), VACCINATION SITE PAIN (area was tender, achiness in the right deltoid), VACCINATION SITE ERYTHEMA (area was pink), VACCINATION SITE SWELLING (area was swollen) and VACCINATION SITE LYMPHADENOPATHY (small swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information reported was antibiotic and two topical ointments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Nausea
Clinical narrative: No appetite; Fatigue; Nauseous; A spontaneous report was received from a 33-year-old female consumer  with unknown race and ethnicity who received Moderna Covid-19 vaccine and experienced fatigue, nausea, and loss of appetite.  The patient's medical history was not provided. No concomitant medications were reported. No information on allergies.  On 08-JAN-2021, prior to the onset of events, patient received her first of two planned doses of Moderna Covid-19 vaccine. She started feeling nauseous, fatigue and loss of appetite since then. It is not known whether the patient received the treatment for the symptoms.   Action taken with 2nd dose of vaccine is not reported.  The outcome of the events fatigue, nausea, and loss of appetite is unknown at the time of report.; Reporter's Comments: This case concerns a 33-year-old female who experienced a NS unexpected event of Decreased appetite and NS expected events of Fatigue and Nausea.  The events occurred the same day as the first dose of mRNA-1273. Treatment not reported.  Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: She had very similar symptoms as me; This spontaneous case was reported by an other health care professional and describes the occurrence of   in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung cancer and COVID-19.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Hypersomnia, Pain, Pain in extremity
Clinical narrative: lost appetite; severe body aches; slept like in a coma; chills; sore arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), DECREASED APPETITE (lost appetite), PAIN (severe body aches), HYPERSOMNIA (slept like in a coma) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Hospitalized for 6 days) in November 2020.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 14-Jan-2021, the patient experienced DECREASED APPETITE (lost appetite), PAIN (severe body aches), HYPERSOMNIA (slept like in a coma) and CHILLS (chills). On 15-Jan-2021, DECREASED APPETITE (lost appetite) had resolved. On 16-Jan-2021, PAIN IN EXTREMITY (sore arm), PAIN (severe body aches), HYPERSOMNIA (slept like in a coma) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided Treatment Motrin 600
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for covid-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Arm Soreness; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm Soreness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for Covid-19 Vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced LIMB DISCOMFORT (Arm Soreness). On 30-Jan-2021, LIMB DISCOMFORT (Arm Soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site discomfort, Injection site erythema, Injection site warmth
Clinical narrative: Redness; warm; injection site was uncomfortable; red spot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), INJECTION SITE WARMTH (warm), INJECTION SITE DISCOMFORT (injection site was uncomfortable) and INJECTION SITE ERYTHEMA (red spot) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Breast cancer.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced ERYTHEMA (Redness), INJECTION SITE WARMTH (warm), INJECTION SITE DISCOMFORT (injection site was uncomfortable) and INJECTION SITE ERYTHEMA (red spot). At the time of the report, ERYTHEMA (Redness), INJECTION SITE WARMTH (warm), INJECTION SITE DISCOMFORT (injection site was uncomfortable) and INJECTION SITE ERYTHEMA (red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided Treatment Cortisone and 2 Benadryl. Also ice pack in the injection site.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, Rash macular
Clinical narrative: red spot; positive for COVID (swab); fever 100°F; This spontaneous case was reported by a non-health professional and describes the occurrence of RASH MACULAR (red spot), COVID-19 (positive for COVID (swab)) and PYREXIA (fever 100°F) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concomitant products included CALCIUM, FISH OIL (OMEGA 3 SELECT) and Vitamin.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 22-Jan-2021, the patient experienced COVID-19 (positive for COVID (swab)) and PYREXIA (fever 100°F). On 25-Jan-2021, the patient experienced RASH MACULAR (red spot). At the time of the report, RASH MACULAR (red spot), COVID-19 (positive for COVID (swab)) and PYREXIA (fever 100°F) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment tylenol or aspirin
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Poor quality sleep, Pruritus
Clinical narrative: Redness; itching; Poor sleep; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PRURITUS (itching), POOR QUALITY SLEEP (Poor sleep) and INJECTION SITE PAIN (Pain at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history reported.).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced INJECTION SITE PAIN (Pain at the injection site). On 24-Jan-2021, the patient experienced ERYTHEMA (Redness), PRURITUS (itching) and POOR QUALITY SLEEP (Poor sleep). On 19-Jan-2021, INJECTION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, ERYTHEMA (Redness), PRURITUS (itching) and POOR QUALITY SLEEP (Poor sleep) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Lethargy, Malaise, Migraine
Clinical narrative: dont want to do anything; Have not been hungry; I just don't feel good; Diarrhea; migraine headache; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (dont want to do anything), DIARRHOEA (Diarrhea), DECREASED APPETITE (Have not been hungry), MALAISE (I just don't feel good) and MIGRAINE (migraine headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Bunion operation (Surgery to remove bunion.) on 06-Jan-2021.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced MIGRAINE (migraine headache). On 24-Jan-2021, the patient experienced DIARRHOEA (Diarrhea). On an unknown date, the patient experienced LETHARGY (dont want to do anything), DECREASED APPETITE (Have not been hungry) and MALAISE (I just don't feel good). On 24-Jan-2021, DIARRHOEA (Diarrhea) outcome was unknown. At the time of the report, LETHARGY (dont want to do anything), DECREASED APPETITE (Have not been hungry), MALAISE (I just don't feel good) and MIGRAINE (migraine headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 26-Jan-2021: Additional information received
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Joint swelling, Pain in extremity, Peripheral swelling, Pyrexia
Clinical narrative: Throwing up; Fever of 99 deg F; severe back pain; feet were swollen up to the knees; feet were swollen up to the knees; arm was sore but not too bad; A spontaneous report was received from a caregiver concerning a female patient of 82 years of age ,who was administered with Moderna's covid-19 vaccine and experienced Throwing up,fever of 99 degree F,severe back pain,feet were swollen upto the knees,arm was sore but not too bad.  Patient's medical was not mentioned.Concomitant medications include Methotrexate for arthritis.  On 29-JAN-2021,prior to the onset of events,patient received the second of two planned doses of mRNA-1273(Lot number:unknown) for prophylaxis of covid-19 infection.  On 30-JAN-2021,the patient's son called to report what there mother was experiencing after receiving her second dose of moderna covid-19 vaccine yesterday 29-JAN-2021.He said that they went to check on their mother and they saw her throwing up and have a fever of 99 degree F.She also had severe back pain and feet were swollen up to the knees and arm of the injection site was sore but not too bad.  The outcome of the events were unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Throwing up; Fever of 99 deg F; severe back pain; feet were swollen up to the knees; feet were swollen up to the knees; arm was sore but not too bad; A spontaneous report was received from a caregiver concerning a female patient of 82 years of age ,who was administered with Moderna's covid-19 vaccine and experienced Throwing up,fever of 99 degree F,severe back pain,feet were swollen upto the knees,arm was sore but not too bad.  Patient's medical was not mentioned.Concomitant medications include Methotrexate for arthritis.  On 29-JAN-2021,prior to the onset of events,patient received the second of two planned doses of mRNA-1273(Lot number:unknown) for prophylaxis of covid-19 infection.  On 30-JAN-2021,the patient's son called to report what there mother was experiencing after receiving her second dose of moderna covid-19 vaccine yesterday 29-JAN-2021.He said that they went to check on their mother and they saw her throwing up and have a fever of 99 degree F.She also had severe back pain and feet were swollen up to the knees and arm of the injection site was sore but not too bad.  The outcome of the events were unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site swelling, Pain in extremity
Clinical narrative: Back and blue marks on injection site; 3 inch swelling of injection site; Sore arms; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE BRUISING (Back and blue marks on injection site), PAIN IN EXTREMITY (Sore arms) and INJECTION SITE SWELLING (3 inch swelling of injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 immunization.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arms). On 30-Jan-2021, the patient experienced INJECTION SITE BRUISING (Back and blue marks on injection site) and INJECTION SITE SWELLING (3 inch swelling of injection site). At the time of the report, INJECTION SITE BRUISING (Back and blue marks on injection site), PAIN IN EXTREMITY (Sore arms) and INJECTION SITE SWELLING (3 inch swelling of injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient wanted to know if these were usual events seen after vaccination. Treatment information was not provided. Concomitant medications were not reported.  Follow-up was performed on 19-Apr-2021. Patient stated his events were resolved. He also withdrew consent to contact him for follow-up.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Outcome resolved
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pruritus, Malaise, Vaccination complication, Vaccination site swelling
Clinical narrative: headache; not feeling well; arm started to swell; itch; warm; adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction), VACCINATION SITE SWELLING (arm started to swell), INJECTION SITE PRURITUS (itch), VACCINATION SITE WARMTH (warm) and MALAISE (not feeling well) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION COMPLICATION (adverse reaction), INJECTION SITE PRURITUS (itch) and VACCINATION SITE WARMTH (warm). On 22-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm started to swell). On 23-Jan-2021, the patient experienced MALAISE (not feeling well). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with ANTIBIOTICS ongoing from 22-Jan-2021 at an unspecified dose and frequency; STEROIDS ongoing from 23-Jan-2021 at an unspecified dose and frequency and ANTIHISTAMINES ongoing from 23-Jan-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (adverse reaction), VACCINATION SITE SWELLING (arm started to swell), INJECTION SITE PRURITUS (itch), VACCINATION SITE WARMTH (warm), MALAISE (not feeling well) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: headache; not feeling well; arm started to swell; itch; warm; adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction), VACCINATION SITE SWELLING (arm started to swell), INJECTION SITE PRURITUS (itch), VACCINATION SITE WARMTH (warm) and MALAISE (not feeling well) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION COMPLICATION (adverse reaction), INJECTION SITE PRURITUS (itch) and VACCINATION SITE WARMTH (warm). On 22-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm started to swell). On 23-Jan-2021, the patient experienced MALAISE (not feeling well). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with ANTIBIOTICS ongoing from 22-Jan-2021 at an unspecified dose and frequency; STEROIDS ongoing from 23-Jan-2021 at an unspecified dose and frequency and ANTIHISTAMINES ongoing from 23-Jan-2021 at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (adverse reaction), VACCINATION SITE SWELLING (arm started to swell), INJECTION SITE PRURITUS (itch), VACCINATION SITE WARMTH (warm), MALAISE (not feeling well) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration
Clinical narrative: has a big bump on the arm; redness on their arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (has a big bump on the arm) and VACCINATION SITE ERYTHEMA (redness on their arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (has a big bump on the arm) and VACCINATION SITE ERYTHEMA (redness on their arm). At the time of the report, VACCINATION SITE INDURATION (has a big bump on the arm) and VACCINATION SITE ERYTHEMA (redness on their arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Rash vesicular
Clinical narrative: extreme fatigue; blisters on my hands, nose, feet, elbows, between my fingers, underneath and between my toes; This spontaneous case was reported by a dental hygienist (subsequently medically confirmed) and describes the occurrence of RASH VESICULAR (blisters on my hands, nose, feet, elbows, between my fingers, underneath and between my toes) and FATIGUE (extreme fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included IgA decreased.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced RASH VESICULAR (blisters on my hands, nose, feet, elbows, between my fingers, underneath and between my toes). On an unknown date, the patient experienced FATIGUE (extreme fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergic rash, at a dose of unknown; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, at a dose of unknown; DOXYCYCLINE for Antibacterial prophylaxis, at a dose of unknown; VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for Antiviral prophylaxis, at a dose of unknown and PREDNISONE ACETATE for Antiinflammatory therapy, at an unspecified dose and frequency. At the time of the report, RASH VESICULAR (blisters on my hands, nose, feet, elbows, between my fingers, underneath and between my toes) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Huge rash  over the upper part of the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Huge rash  over the upper part of the arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No medical history is provided and concomitant drugs are provided.  Concomitant products included ATORVASTATIN, LORATADINE and TENOXICAM (SORAL).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (Huge rash  over the upper part of the arm). At the time of the report, VACCINATION SITE RASH (Huge rash  over the upper part of the arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       having a reaction is a event is not resolved
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: 1st dose of Moderna Covid 19 vaccine; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (1st dose of Moderna COVID 19 vaccine) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (1st dose of Moderna Covid 19 vaccine) and NAUSEA (nausea). At the time of the report, MYALGIA (1st dose of Moderna Covid 19 vaccine) outcome was unknown and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Pain in extremity, Pyrexia
Clinical narrative: low grade fever; arm soreness; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever), PAIN IN EXTREMITY (arm soreness) and INJECTION SITE SWELLING (swelling at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (low grade fever), PAIN IN EXTREMITY (arm soreness) and INJECTION SITE SWELLING (swelling at the injection site). At the time of the report, PYREXIA (low grade fever), PAIN IN EXTREMITY (arm soreness) and INJECTION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event following immunisation
Clinical narrative: side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNIZATION (side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (side effects). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Rash erythematous, Swelling, Unevaluable event
Clinical narrative: swelling; red rash; hot; localized reaction; This spontaneous case was reported by a physician and describes the occurrence of SWELLING (swelling), RASH ERYTHEMATOUS (red rash), FEELING HOT (hot) and UNEVALUABLE EVENT (localized reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), RASH ERYTHEMATOUS (red rash), FEELING HOT (hot) and UNEVALUABLE EVENT (localized reaction). At the time of the report, SWELLING (swelling), RASH ERYTHEMATOUS (red rash), FEELING HOT (hot) and UNEVALUABLE EVENT (localized reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Rash maculo-papular, Vaccination site bruising, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: macular, papular area; injection site is still bruised; injection site itchy; injection site is red; injection site is swollen; This spontaneous case was reported by a physician and describes the occurrence of RASH MACULO-PAPULAR (macular, papular area), VACCINATION SITE BRUISING (injection site is still bruised), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced RASH MACULO-PAPULAR (macular, papular area), VACCINATION SITE BRUISING (injection site is still bruised), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen). At the time of the report, RASH MACULO-PAPULAR (macular, papular area), VACCINATION SITE BRUISING (injection site is still bruised), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact.
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Pain in extremity, Peripheral swelling, Swelling, Vaccination site erythema
Clinical narrative: redness (vaccination site); Arm pain; Swollen arm; Swollen neck; Dry Mouth; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness (vaccination site)), PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (Swollen arm), SWELLING (Swollen neck) and DRY MOUTH (Dry Mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L2U9) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE for Blood pressure abnormal.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness (vaccination site)), PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (Swollen arm), SWELLING (Swollen neck) and DRY MOUTH (Dry Mouth). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE ERYTHEMA (redness (vaccination site)), PAIN IN EXTREMITY (Arm pain), PERIPHERAL SWELLING (Swollen arm), SWELLING (Swollen neck) and DRY MOUTH (Dry Mouth) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  For mRNA-1273 (COVID 19 Vaccine Moderna) administered intramuscularly, the reporter did not provide any causality assessments.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Paraesthesia, Peripheral swelling, Vomiting
Clinical narrative: Right arm was swollen; Tingling Sensation down to finger; Severe headache very intense; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Right arm was swollen), PARAESTHESIA (Tingling Sensation down to finger), HEADACHE (Severe headache very intense), NAUSEA (Nausea) and VOMITING (Vomiting) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported). Concomitant products included ACETAMINOPHEN and IBUPROFEN (ADVIL 12 HOUR) for an unknown indication.   On 23-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Right arm was swollen), PARAESTHESIA (Tingling Sensation down to finger), HEADACHE (Severe headache very intense), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, PERIPHERAL SWELLING (Right arm was swollen), PARAESTHESIA (Tingling Sensation down to finger), HEADACHE (Severe headache very intense), NAUSEA (Nausea) and VOMITING (Vomiting) had not resolved.      No treatment information was provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site swelling
Clinical narrative: lump on left arm at the injection site; Redness on left arm at the injection site; swelling on left arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump on left arm at the injection site), VACCINATION SITE ERYTHEMA (Redness on left arm at the injection site) and VACCINATION SITE SWELLING (swelling on left arm at the injection site) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE MASS (lump on left arm at the injection site), VACCINATION SITE ERYTHEMA (Redness on left arm at the injection site) and VACCINATION SITE SWELLING (swelling on left arm at the injection site). At the time of the report, VACCINATION SITE MASS (lump on left arm at the injection site), VACCINATION SITE ERYTHEMA (Redness on left arm at the injection site) and VACCINATION SITE SWELLING (swelling on left arm at the injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.